Hob Biotech Group Corp., Ltd(688656.SH) collaborates with Roche Diagnostics in the field of chemiluminescent autoantibody detection products.

Hob Biotech Group Corp., Ltd (688656.SH) announced that the company has signed a "Cooperation Framework Agreement" with Roche Diagnostics Products (Shanghai) Co., Ltd. (referred to as "Roche Diagnostics"), and the two parties will cooperate in the field of chemiluminescent self-antibody testing products. The signing of the "Cooperation Framework Agreement" is an important step in implementing the company's long-term development strategy. The collaboration with Roche Diagnostics will enhance the company's brand recognition in the domestic market and further expand the company's market share in the field of diagnostic reagents, which is of positive significance for the company's development. The company will use this cooperation to communicate and learn from each other, continuously improve its own level, and provide customers with higher quality products and services. The "Cooperation Framework Agreement" signed this time is a framework statement based on the mutual cooperation intention of both parties, and it does not constitute mandatory legal obligations nor serve as a basis for holding each other accountable for breach of contract. Specific cooperation projects will require separate cooperation agreements to be signed, and there is a certain level of uncertainty in whether the cooperation between the two parties can be successfully implemented.